Literature DB >> 19276807

Human oocyte cryopreservation.

Tao Tao1, Wenling Zhang, Alfonso Del Valle.   

Abstract

PURPOSE OF REVIEW: This review summarized the clinical breakthroughs in the human oocyte cryopreservation field in the past 2 years and gave special emphasis on the role of vitrification method. Human oocyte cryopreservation is an attractive strategy to preserve female fertility, as it offers more opportunities to the future destination of the female gametes and also raises fewer legal and ethical questions compared with embryo cryopreservation. It became promising in recent years because of dramatic improvement in cryopreservation technologies. Human oocyte cryopreservation would not become a clinical routine until the availability of reliable cryopreservation methods and long-term follow-up results of the babies born by this technique. RECENT
FINDINGS: Oocyte cryopreservation produced very exciting results with pregnancy and implantation rates comparable to embryo cryopreservation and in some cases comparable to fresh in-vitro fertilization cycles with both modified slow-freezing and vitrification methods. A cancer patient conceived and delivered her own babies by this technology after recovery from the disease. Oocyte cryopreservation became a new focus in assisted reproductive technology.
SUMMARY: We witnessed the advanced development of human oocyte cryopreservation in the past years because of increasing demand, medically, legally and ethically, and also because of the dramatic improvement of the freezing technique. There is still a long way to go to integrate it into a routine clinical procedure to benefit more patients and encourage clinicians to follow the standard protocols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276807     DOI: 10.1097/GCO.0b013e328329c2d2

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  8 in total

1.  In-vitro maturation of human oocytes: before or after vitrification?

Authors:  Giovanna Fasano; Isabelle Demeestere; Yvon Englert
Journal:  J Assist Reprod Genet       Date:  2012-04-04       Impact factor: 3.412

2.  Emerging technologies in medical applications of minimum volume vitrification.

Authors:  Xiaohui Zhang; Paolo N Catalano; Umut Atakan Gurkan; Imran Khimji; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-08       Impact factor: 5.307

Review 3.  Clinical cases in oncofertility.

Authors:  Laxmi A Kondapalli; Fanzhen Hong; Clarisa R Gracia
Journal:  Cancer Treat Res       Date:  2010

4.  Nanoliter droplet vitrification for oocyte cryopreservation.

Authors:  Xiaohui Zhang; Imran Khimji; Lei Shao; Hooman Safaee; Khanjan Desai; Hasan Onur Keles; Umut Atakan Gurkan; Emre Kayaalp; Aida Nureddin; Raymond M Anchan; Richard L Maas; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-12-21       Impact factor: 5.307

5.  Fertility preservation in young females with non-gynaecologic malignancy: an emerging speciality.

Authors:  C Smyth; I Robertson; L Higgins; K Memeh; M O'Leary; M Keane; W Khan; K Barry
Journal:  Ir J Med Sci       Date:  2013-06-06       Impact factor: 1.568

6.  Correlation of oocyte morphometry parameters with woman's age.

Authors:  Claudia Valeri; Sebastiana Pappalardo; Massimo De Felici; Claudio Manna
Journal:  J Assist Reprod Genet       Date:  2011-04-06       Impact factor: 3.412

7.  Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation.

Authors:  Giovanna Fasano; Federica Moffa; Julie Dechène; Yvon Englert; Isabelle Demeestere
Journal:  Reprod Biol Endocrinol       Date:  2011-11-23       Impact factor: 5.211

8.  Oocyte cryostorage to preserve fertility in oncological patients.

Authors:  Alberto Revelli; Emanuela Molinari; Francesca Salvagno; Luisa Delle Piane; Elisabetta Dolfin; Simona Ochetti
Journal:  Obstet Gynecol Int       Date:  2012-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.